Pharmacokinetics of Temsavir, the Active Moiety of the Prodrug Fostemsavir, in Subjects with Hepatic Impairment

BACKGROUND: Fostemsavir (FTR) is a prodrug of temsavir (TMR), a first-in-class attachment inhibitor that binds directly to HIV-1 gp120, preventing initial viral attachment and entry into host CD4+ T cells. TMR is primarily metabolized via hydrolytic and oxidative pathways; impaired hepatic function...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Main Authors: Sevinsky, Heather, Magee, Mindy, Ackerman, Peter, Adamczyk, Robert, Karkas, Jennifer, Lubin, Susan, Ravindran, Palanikumar, Llamoso, Cyril, Eley, Timothy, Moore, Katy
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5630802/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.1086
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares